 both in their anatomic
and physiologic features, makes application of guidelines
problematic. Often patients do not mesh cleanly with the
criteria established for clinical trial eligibility.
We also recognize that the very criteria used to define
patient cohorts are subject to change. For example, we have
used degree of stenosis to define various patient cohorts
throughout. Symptomatic patients with ‚¨ç50% stenosis are
determined to be best served by medical therapy